531 related articles for article (PubMed ID: 7925194)
21. A physiologically based pharmacokinetic description of the oral uptake, tissue dosimetry, and rates of metabolism of bromodichloromethane in the male rat.
Lilly PD; Andersen ME; Ross TM; Pegram RA
Toxicol Appl Pharmacol; 1998 Jun; 150(2):205-17. PubMed ID: 9653052
[TBL] [Abstract][Full Text] [Related]
22. Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans.
Corley RA; Bormett GA; Ghanayem BI
Toxicol Appl Pharmacol; 1994 Nov; 129(1):61-79. PubMed ID: 7974497
[TBL] [Abstract][Full Text] [Related]
23. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
24. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
[TBL] [Abstract][Full Text] [Related]
25. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and metabolism of vinyl fluoride in vivo and in vitro.
Cantoreggi S; Keller DA
Toxicol Appl Pharmacol; 1997 Mar; 143(1):130-9. PubMed ID: 9073601
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
28. A PBPK model for midazolam in four avian species.
Cortright KA; Wetzlich SE; Craigmill AL
J Vet Pharmacol Ther; 2009 Dec; 32(6):552-65. PubMed ID: 20444010
[TBL] [Abstract][Full Text] [Related]
29. Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE).
Gearhart JM; Mahle DA; Greene RJ; Seckel CS; Flemming CD; Fisher JW; Clewell HJ
Toxicol Lett; 1993 May; 68(1-2):131-44. PubMed ID: 8516760
[TBL] [Abstract][Full Text] [Related]
30. Comparative inter-species pharmacokinetics of phenoxyacetic acid herbicides and related organic acids. evidence that the dog is not a relevant species for evaluation of human health risk.
Timchalk C
Toxicology; 2004 Jul; 200(1):1-19. PubMed ID: 15158559
[TBL] [Abstract][Full Text] [Related]
31. PBPK models in risk assessment--A focus on chloroprene.
DeWoskin RS
Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
[TBL] [Abstract][Full Text] [Related]
32. Development of a physiologically based pharmacokinetic model for chlorobenzene in F-344 rats.
Thrall KD; Woodstock AD; Kania MR
J Toxicol Environ Health A; 2004 Apr; 67(7):525-36. PubMed ID: 15129550
[TBL] [Abstract][Full Text] [Related]
33. Distribution and unspecific protein binding of the xenoestrogens bisphenol A and daidzein.
Csanády GA; Oberste-Frielinghaus HR; Semder B; Baur C; Schneider KT; Filser JG
Arch Toxicol; 2002 Jun; 76(5-6):299-305. PubMed ID: 12107647
[TBL] [Abstract][Full Text] [Related]
34. Prediction of human pharmacokinetics and tissue distribution of apicidin, a potent histone deacetylase inhibitor, by physiologically based pharmacokinetic modeling.
Shin BS; Bulitta JB; Balthasar JP; Kim M; Choi Y; Yoo SD
Cancer Chemother Pharmacol; 2011 Aug; 68(2):465-75. PubMed ID: 21069337
[TBL] [Abstract][Full Text] [Related]
35. Determination of age and gender differences in biochemical processes affecting the disposition of 2-butoxyethanol and its metabolites in mice and rats to improve PBPK modeling.
Corley RA; Grant DM; Farris E; Weitz KK; Soelberg JJ; Thrall KD; Poet TS
Toxicol Lett; 2005 Mar; 156(1):127-61. PubMed ID: 15705493
[TBL] [Abstract][Full Text] [Related]
36. Physiologically-based toxicokinetic modeling of durene (1,2,3,5-tetramethylbenzene) and isodurene (1,2,4,5-tetramethylbenzene) in humans.
Jałowiecki P; Janasik B
Int J Occup Med Environ Health; 2007; 20(2):155-65. PubMed ID: 17638682
[TBL] [Abstract][Full Text] [Related]
37. Physiologically based modeling of the inhalation pharmacokinetics of ethylbenzene in B6C3F1 mice.
Nong A; Charest-Tardif G; Tardif R; Lewis DF; Sweeney LM; Gargas ML; Krishnan K
J Toxicol Environ Health A; 2007 Nov; 70(21):1838-48. PubMed ID: 17934956
[TBL] [Abstract][Full Text] [Related]
38. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
39. Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids.
Okezaki E; Terasaki T; Nakamura M; Nagata O; Kato H; Tsuji A
Drug Metab Dispos; 1988; 16(6):865-74. PubMed ID: 2907467
[TBL] [Abstract][Full Text] [Related]
40. In vivo metabolism of chloroform in B6C3F1 mice determined by the method of gas uptake: the effects of body temperature on tissue partition coefficients and metabolism.
Gearhart JM; Seckel C; Vinegar A
Toxicol Appl Pharmacol; 1993 Apr; 119(2):258-66. PubMed ID: 8480334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
